Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
Autor: | Barbara D. Jakobs, Lisa Spannagel, Vladimir Purvanov, Edith Uetz-von Allmen, Christoph Matti, Daniel F. Legler |
---|---|
Rok vydání: | 2019 |
Předmět: |
chemokine receptor
CCR7 chemokines CCL19 nanobodies 2-adrenergic receptor bimolecular fluorescence complementation split-luciferase complementation β2-adrenergic receptor Receptors CCR7 Antibody Affinity chemical and pharmacologic phenomena Article lcsh:Chemistry ddc:570 Cell Line Tumor Receptors Adrenergic beta Humans lcsh:QH301-705.5 hemic and immune systems Single-Domain Antibodies HEK293 Cells lcsh:Biology (General) lcsh:QD1-999 Single-Chain Antibodies |
Zdroj: | International Journal of Molecular Sciences Volume 20 Issue 10 International Journal of Molecular Sciences, Vol 20, Iss 10, p 2597 (2019) |
ISSN: | 1422-0067 |
Popis: | The chemokine receptor CCR7 plays a pivotal role in health and disease. In particular, CCR7 controls homing of antigen-bearing dendritic cells and T cells to lymph nodes, where adaptive immune responses are initiated. However, CCR7 also guides T cells to inflamed synovium and thereby contributes to rheumatoid arthritis and promotes cancer cell migration and metastasis formation. Nanobodies have recently emerged as versatile tools to study G-protein-coupled receptor functions and are being tested in diagnostics and therapeutics. In this study, we designed a strategy to engineer novel nanobodies recognizing human CCR7. We generated a nanobody library based on a solved crystal structure of the nanobody Nb80 recognizing the &beta 2-adrenergic receptor (&beta 2AR) and by specifically randomizing two segments within complementarity determining region 1 (CDR1) and CDR3 of Nb80 known to interact with &beta 2AR. We fused the nanobody library to one half of split-YFP in order to identify individual nanobody clones interacting with CCR7 fused to the other half of split-YFP using bimolecular fluorescence complementation. We present three novel nanobodies, termed Nb1, Nb5, and Nb38, that recognize human CCR7 without interfering with G-protein-coupling and downstream signaling. Moreover, we were able to follow CCR7 trafficking upon CCL19 triggering using Nb1, Nb5, and Nb38. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |